
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0 | 0 | 0 |
Stocks | 100 | 100 | 0 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 14 | 15 |
Price to Book | 2 | 2 |
Price to Sales | 1 | 1 |
Price to Cash Flow | 10 | 10 |
Dividend Yield | 4 | 3 |
5 Years Earnings Growth | 11 | 10 |
Name | Net % | Category Average |
---|---|---|
Financial Services | 22 | 19 |
Industrials | 20 | 18 |
Technology | 14 | 15 |
Consumer Cyclical | 11 | 12 |
Healthcare | 7 | 8 |
Consumer Defensive | 6 | 7 |
Basic Materials | 5 | 6 |
Utilities | 5 | 5 |
Communication Services | 4 | 6 |
Energy | 3 | 4 |
Real Estate | 2 | 2 |
Number of long holdings: 113
Number of short holdings: 6
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
SAP | DE0007164600 | 5.39 | 223.800 | +1.08% | |
ASML Holding | NL0010273215 | 5.27 | 573.80 | +4.33% | |
Siemens AG | DE0007236101 | 3.40 | 182.74 | +3.48% | |
Schneider Electric | FR0000121972 | 3.02 | 192.34 | +3.10% | |
Louis Vuitton | FR0000121014 | 2.84 | 519.80 | +2.40% | |
Allianz | DE0008404005 | 2.80 | 325.10 | +2.88% | |
TotalEnergies SE | FR0000120271 | 2.73 | 50.45 | +0.32% | |
Sanofi | FR0000120578 | 2.68 | 93.18 | +1.94% | |
UniCredit | IT0005239360 | 2.35 | 43.595 | +2.22% | |
BBVA | ES0113211835 | 2.25 | 10.820 | +0.09% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Afer Sfer | 4.5B | 6.81 | 4.86 | 4.29 | ||
Afer Actions Euro A | 1.99B | 10.61 | 12.32 | 6.11 | ||
FR0010094839 | 1.51B | 1.29 | 10.77 | 8.68 | ||
Aviva Investors Conviction | 1.46B | 4.49 | 9.13 | 6.36 | ||
Aviva Investors Valorisation | 1.43B | 2.95 | 4.79 | 3.92 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review